Skip to content
OpenCapital
Get started

Edwards Lifesciences EW Operating Income

Operating Income at other companies

Cabot Corporation logo
Cabot CorporationCBT
$129M-20.4%
Travel + Leisure logo
Travel + LeisureTNL
$159M+1.9%
Unifirst logo
UnifirstUNF
$26.01M-16.7%
HES
Hess MidstreamHESM
$238.1M+0.3%
MAG
MagneraMAGN
$17M+325%
Caleres logo
CaleresCAL
$23.87M+106%

Other financials

Income statement

See full
Revenue$1.6B+16.7%
Gross profit$1.3B+15.7%
Net income$380.7M+6.3%
EPS (diluted)$0.66+8.2%

Balance sheet

See full
Cash & equivalents$2.4B-22.3%
Total debt$702.9M+0.5%
Total equity$10.3B+2.0%
Total assets$13.3B+2.3%

Cash flow

See full
Operating cash flow$43.8M-84.4%
CapEx$64.9M+15.9%
Free cash flow-$21.1M-109%

Valuation

See full
Market cap$51.66B+19.3%
Enterprise value$49.92B+22.2%
P/E47.1×+36.8×
P/S8.2×+0.4×

Profitability

See full
Gross margin77.9%-1.6pp
Operating margin21.4%-4.4pp
Net margin17.4%-58.3pp
FCF margin17.3%—

Returns & leverage

See full
Return on equity10.7%-37.8pp
Debt / equity0.1×0.0×
Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edwards Lifesciences's operating income?
Edwards Lifesciences (EW) reported operating income of $477.6M in Q1 2026.
How has Edwards Lifesciences's operating income changed year-over-year?
Edwards Lifesciences's operating income increased by 21.0% year-over-year, from $394.8M to $477.6M.
What is the long-term trend for Edwards Lifesciences's operating income?
Over 4 years (2021 to 2025), Edwards Lifesciences's operating income has grown at a -7.0% compound annual growth rate (CAGR), from $1.69B to $1.26B.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.